Ledger.Open graph →
SEC Form D · filed December 22, 2020

Faze Medicines, Inc

Offering
$81.0M
Sold
$30.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Robert Tepper · Cambridge, MADirectorCary Pfeffer · Cambridge, MAExec · DirectorRobert Tepper · Newton, MADirectorEd Freedman · Cambridge, MAExec · DirectorCharles Homcy · South San Francisco, CADirectorCharles Homcy · South San Francisco, CADirectorEd Freedman · Cambridge, MAExec · DirectorCary Pfeffer · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗